Polymer matrix of fiber-reinforced composites: Changes in the semi-interpenetrating polymer network during the shelf life

Khan, Aftab A.,Al-Kheraif, Abdulaziz A.,Al-Shehri, Abdullah M.,Sä,ilynoja, Eija,Vallittu, Pekka K. Elsevier 2018 Journal of the mechanical behavior of biomedical m Vol.78 No.-

<P><B>Abstract</B></P> <P>This laboratory study was aimed to characterize semi-interpenetrating polymer network (semi-IPN) of fiber-reinforced composite (FRC) prepregs that had been stored for up to two years before curing. Resin impregnated prepregs of everStick C&B (StickTech-GC, Turku, Finland) glass FRC were stored at 4°C for various lengths of time, <I>i.e.</I>, two-weeks, 6-months and 2-years. Five samples from each time group were prepared with a light initiated free radical polymerization method, which were embedded to its long axis in self-curing acrylic. The nanoindentation readings on the top surface toward the core of the sample were made for five test groups, which were named as “stage 1–5”. To evaluate the nanohardness and modulus of elasticity of the polymer matrix, a total of 4 slices (100µm each) were cut from stage 1 to stage 5. Differences in nanohardness values were evaluated with analysis of variance (ANOVA), and regression model was used to develop contributing effect of the material's different stages to the total variability in the nanomechanical properties. Additional chemical and thermal characterization of the polymer matrix structure of FRC was carried out. It was hypothesized that time of storage may have an influence on the semi-IPN polymer structure of the cured FRC. The two-way ANOVA test revealed that the storage time had no significant effect on the nanohardness of FRC (p = 0.374). However, a highly significant difference in nanohardness values was observed between the different stages of FRC (P<0.001). The regression coefficient suggests nanohardness increased on average by 0.039GPa for every storage group. The increased nanohardness values in the core region of 6-months and 2-years stored prepregs might be due to phase-segregation of components of semi-IPN structure of FRC prepregs before their use. This may have an influence to the surface bonding properties of the cured FRC.</P>

Outcome of Palliative and Radical Radiotherapy in Patients with Oral Squamous Cell Carcinoma - a Retrospective Study

Rai, Narendra Prakash,Divakar, Darshan Devang,Al Kheraif, Abdulaziz Abdullah,Ramakrishnaiah, Ravikumar,Mustafa, Shabil Mohamed,Durgesh, BH,Basavarajappa, Santhosh,Khan, Aftab Ahmed Asian Pacific Journal of Cancer Prevention 2015 Asian Pacific journal of cancer prevention Vol.16 No.16

Background: The treatment selection for the oral squamous cell carcinoma remains controversial. Radiation therapy or surgical excision of the lesion can be applied as the sole treatment or it can be used in combination with other treatment modalities. Radiotherapy is considered to be the safest of all the treatment modalities and can be used in several situations for oral and oropharyngeal cancers. The aim of this study was to evaluate the survival outcome differences in patients treated with radical and palliative radiotherapy as the primary treatment modality. Materials and Methods: The study included a total of 47 patients with oral cancer reporting to our hospital between years 2009 to 2010. The age group for the selected patients was more than 65 years, treated with radical and palliative radiotherapy with no prior surgical interventions. Patients were evaluated till Dec 2013 for overall survival time. Results: Twenty nine patients were treated with radical radiotherapy as main stay of treatment, out of which 21 died during the follow up time with median survival of $352{\pm}281.7$ days with 8 patients alive. All the 16 patients were dead who received palliative radiotherapy with a median survival time of $112{\pm}144.0$ days. Conclusions: This retrospective study showed improved overall survival time, loco regional control rates and reduced morbidity in patients treated with radical radiotherapy when compared to patients treated with palliative radiotherapy.

End Stage Palliative Care of Head and Neck Cancer: a Case Study

Shishodia, Nitin Pratap,Divakar, Darshan Devang,Al Kheraif, Abdulaziz Abdullah,Ramakrishnaiah, Ravikumar,Pathan, Akbar Ali Khan,Parine, Narasimha Reddy,Chandroth, Santhosh Vediyera,Purushothaman, Binu Asian Pacific Journal of Cancer Prevention 2015 Asian Pacific journal of cancer prevention Vol.16 No.3

Background: Locally advanced head and neck cancer is generally incurable and has a short survival rate. This study aimed to evaluate symptom relief, disease response, and acute toxicity after palliative hypo-fractionated radiotherapy and long-term survival in affected patients. Materials and Methods: Between January 2011 to December 2011, 80 patients who were histopathologically diagnosed as having stage III or stage IV head and neck squamous cell carcinoma based on Eastern Cooperative Oncology Group (ECOG) performance status 1-3, were offered palliative radiotherapy (20 Gy/5Fr/5 Days). Later these patients were evaluated on 30th day after completion of treatment for disease response based on World Health Organisation (WHO) criteria and palliation of symptoms using symptomatic response grading and acute toxicities by the Radiation Therapy Oncology Group (RTOG). Many patients were given post radiation therapy (RT) palliative chemotherapy for appropriate palliative care and a few patients were selected for further curative RT. The overall survival was also evaluated among this group of patients with last follow up date of 1st May, 2014. Results: The most common presenting complaint was pain followed by dysphagia. Most patients (60-70%) had appreciable relief in their presenting symptoms. A good response was observed in the majority following palliative RT; a few patients had progressive disease and some had stable and regressed disease. None of the patients experienced radiation toxicity that required hospital admission. Almost all showed grade one and two acute skin and mucosal toxicity one month after completion of treatment. The mean survival days for patients given only hypofractionated palliative RT was 307 days, those with post palliative RT and palliative chemotherapy was 390 days and patients who went on to receive further palliative RT and curative RT dose had significantly overall survival of 582 days. Conclusions: Advanced head and neck cancer should be identified for suitable palliative hypofractionated radiotherapy to achieve acceptable symptom relief in a great proportion of patients and should be followed by palliative chemotherapy or curative RT in suitable cases for long-term symptom-free survival.

Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients

Rai, Narendra Prakash,Anekar, Jayaprasad,Shivaraja, Shankara YM,Divakar, Darshan Devang,Al Kheraif, Abdulaziz Abdullah,Ramakrishnaiah, Ravikumar,Sebastian, Roopa,Raj, AC,Al-Hazmi, Ali,Mustafa, habil M Asian Pacific Journal of Cancer Prevention 2015 Asian Pacific journal of cancer prevention Vol.16 No.17

Background: Tumor markers, designated as a broad group of substances produced by malignancies, could be in the form of biochemical substances, immunological substances, cell surface changes and genetic alterations. Cancer, a disorder of cellular behavior is characterized by alteration of serum glycoproteins. L-fucose, a hexose, which is the terminal sugar in most of the plasma glycoproteins, may be useful as a tumor marker for the detection, monitoring and prognostic assessment of malignancies. The aim of the study was to ascertain the role of serum fucose as a biomarker for early detection of oral cancer and to compare serum fucose levels in healthy controls, leukoplakia and oral cancer patients. Materials and Methods: The study included 60 (100.0%) subjects, who were grouped as 20 (33.3%) control subjects, 20 (33.3%) squamous cell carcinoma patients and 20 (33.3%) leukoplakia patients. Fucose estimation was done using UV-visible spectrophotometry based on the method as adopted by Winzler using cysteine reagent. The results were analyzed statistically using ANOVA with Bonferroni post hoc tests. Results: Results showed a high significance in serum fucose in oral squamous cell carcinoma (OSCC) and leukoplakia subjects compared to normal controls. There was a gradual increase in the values noted from control to leukoplakia and to squamous cell carcinoma. Conclusions: Estimation of serum fucose may be a reliable marker and can be used as an effective diagnostic biomarker in oral squamous cell carcinoma patients.